1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 POLICY COMMITTEE
RECOMMENDATION
4 FOR
HOUSE BILL NO. 2298 By: Hilbert
5
6
7
8 POLICY COMMITTEE RECOMMENDATION
9 An Act relating to the practice of nursing; providing
for independent prescriptive authority of Advanced
10 Practice Registered Nurses who meet certain
requirements; stating application criteria;
11 specifying duration of authority; providing for
application approval, denial, reapplication, fees,
12 and independent prescriptive authority revocation;
prescribing certain malpractice insurance
13 requirements; directing promulgation of certain
advertising rules; providing certain construction;
14 directing certain boards to make specified
information available online; amending 59 O.S. 2021,
15 Section 353.1, as amended by Section 6, Chapter 288,
O.S.L. 2022 (59 O.S. Supp. 2024, Section 353.1),
16 which relates to definitions used in the Oklahoma
Pharmacy Act; modifying and adding definitions;
17 amending 59 O.S. 2021, Section 353.1a, which relates
to prescriptive authority of Advanced Practice
18 Registered Nurses; modifying prescriptive authority
of certain Advanced Practice Registered Nurses;
19 updating statutory language; amending 59 O.S. 2021,
Section 567.3a, which relates to definitions used in
20 the Oklahoma Nursing Practice Act; modifying and
adding definitions; amending 59 O.S. 2021, Section
21 567.4a, which relates to prescriptive authority;
specifying authority of the Oklahoma Board of Nursing
22 to grant prescriptive authority; directing the Board
to promulgate certain rules; clarifying certain
23 educational requirement; requiring the Formulary
Advisory Council to develop, update, and publish
24 certain guidelines; modifying references; conforming
Req. No. 12910 Page 1

1 language; amending 59 O.S. 2021, Section 567.5a, as
amended by Section 1, Chapter 94, O.S.L. 2024 (59
2 O.S. Supp. 2024, Section 567.5a), which relates to
Advanced Practice Registered Nurse license; providing
3 for independent prescriptive authority by
endorsement; amending 63 O.S. 2021, Section 2-312, as
4 amended by Section 2, Chapter 184, O.S.L. 2022 (63
O.S. Supp. 2024, Section 2-312), which relates to
5 controlled dangerous substances; conforming language
relating to supervision requirement; updating
6 statutory references and language; providing for
codification; and providing an effective date.
7
8
9 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
10 SECTION 1. NEW LAW A new section of law to be codified
11 in the Oklahoma Statutes as Section 567.4c of Title 59, unless there
12 is created a duplication in numbering, reads as follows:
13 A. 1. An Advanced Practice Registered Nurse recognized by the
14 Oklahoma Board of Nursing as a Certified Nurse Practitioner,
15 Clinical Nurse Specialist, or Certified Nurse-Midwife who has
16 completed a minimum of three (3) years of practice with prescriptive
17 authority supervised by a physician may apply to the Oklahoma Board
18 of Nursing for authority to prescribe and order independent of
19 supervision.
20 2. The application for independent prescriptive authority shall
21 include proof that the Certified Nurse Practitioner, Clinical Nurse
22 Specialist, or Certified Nurse-Midwife:
23
24
Req. No. 12910 Page 2

1 a. holds a valid, current license in the appropriate
2 Advanced Practice Registered Nurse role issued by the
3 Board and is in good standing with the Board, and
4 b. has completed a minimum of three (3) years of practice
5 with prescriptive authority supervised by a physician.
6 3. Independent prescriptive authority granted under this
7 subsection shall be valid until the expiration of the current
8 license to practice and may be renewed upon application to the Board
9 at the same time and for the same period as the renewal of the
10 license to practice.
11 B. The Board shall review any application submitted under this
12 section and shall approve or deny the application, stating the
13 reason or reasons for denial, if denied. If denied, the applicant
14 may reapply using the process prescribed by subsection A of this
15 section.
16 C. The Board may suspend or revoke independent prescriptive
17 authority granted under this section for good cause at any time.
18 D. The Board may establish a fee for the review of initial and
19 renewal applications under the provisions of this section.
20 SECTION 2. NEW LAW A new section of law to be codified
21 in the Oklahoma Statutes as Section 567.5b of Title 59, unless there
22 is created a duplication in numbering, reads as follows:
23 A. An Advanced Practice Registered Nurse, or the employer of
24 the Advanced Practice Registered Nurse on his or her behalf, shall
Req. No. 12910 Page 3

1 carr y malpractice insurance or demonstrate proof of financial
2 responsibility in a minimum amount of One Million Dollars
3 ($1,000,000.00) per occurrence and Three Million Dollars
4 ($3,000,000.00) in the aggregate per year.
5 B. An Advanced Practice Registered Nurse who is employed by or
6 under contract with a federal agency that carries malpractice
7 insurance in any amount on behalf of the Advanced Practice
8 Registered Nurse shall be deemed in compliance with subsection A of
9 this section when practicing under such federal employment or
10 contract. However, to the extent the Advanced Practice Registered
11 Nurse practices outside of such federal employment or contract, the
12 Advanced Practice Registered Nurse, or his or her employer, shall
13 comply with subsection A of this section.
14 SECTION 3. NEW LAW A new section of law to be codified
15 in the Oklahoma Statutes as Section 567.5c of Title 59, unless there
16 is created a duplication in numbering, reads as follows:
17 A. The Oklahoma Board of Nursing shall promulgate rules
18 governing advertising of health care services by Advanced Practice
19 Registered Nurses to include, but not be limited to, the specialty
20 areas or types of health care services Advanced Practice Registered
21 Nurses may advertise based on their training or experience.
22 B. Nothing in this act shall be construed to allow an Advanced
23 Practice Registered Nurse to perform any medical service or
24
Req. No. 12910 Page 4

1 pres cribe any medication beyond those authorized under state law or
2 in a manner otherwise inconsistent with state law.
3 SECTION 4. NEW LAW A new section of law to be codified
4 in the Oklahoma Statutes as Section 479 of Title 59, unless there is
5 created a duplication in numbering, reads as follows:
6 The State Board of Medical Licensure and Supervision and the
7 State Board of Osteopathic Examiners shall make available, and keep
8 updated, in a conspicuous location on the website of each Board a
9 list of physicians who are available to supervise Advanced Practice
10 Registered Nurses. The Boards shall develop procedures necessary
11 for the implementation of this section.
12 SECTION 5. AMENDATORY 59 O.S. 2021, Section 353.1, as
13 amended by Section 6, Chapter 288, O.S.L. 2022 (59 O.S. Supp. 2024,
14 Section 353.1), is amended to read as follows:
15 Section 353.1. For the purposes of the Oklahoma Pharmacy Act:
16 1. “Accredited program” means those seminars, classes,
17 meetings, work projects, and other educational courses approved by
18 the Board State Board of Pharmacy for purposes of continuing
19 professional education;
20 2. “Act” means the Oklahoma Pharmacy Act;
21 3. “Administer” means the direct application of a drug, whether
22 by injection, inhalation, ingestion, or any other means, to the body
23 of a patient;
24
Req. No. 12910 Page 5

1 4. “Assistant pharmacist” means any person presently licensed
2 as an assistant pharmacist in the State of Oklahoma this state by
3 the Board pursuant to Section 353.10 of this title and for the
4 purposes of the Oklahoma Pharmacy Act shall be considered the same
5 as a pharmacist, except where otherwise specified;
6 5. “Board” or “State Board” means the State Board of Pharmacy;
7 6. “Certify” or “certification of a prescription” means the
8 review of a filled prescription by a licensed pharmacist or a
9 licensed practitioner with dispensing authority to confirm that the
10 medication, labeling, and packaging of the filled prescription are
11 accurate and meet all requirements prescribed by state and federal
12 law. For the purposes of this paragraph, “licensed practitioner”
13 shall not include optometrists with dispensing authority;
14 7. “Chemical” means any medicinal substance, whether simple or
15 compound or obtained through the process of the science and art of
16 chemistry, whether of organic or inorganic origin;
17 8. “Compounding” means the combining, admixing, mixing,
18 diluting, pooling, reconstituting, or otherwise altering of a drug
19 or bulk drug substance to create a drug. Compounding includes the
20 preparation of drugs or devices in anticipation of prescription drug
21 orders based on routine, regularly observed prescribing patterns;
22 9. “Continuing professional education” means professional,
23 pharmaceutical education in the general areas of the socioeconomic
24 and legal aspects of health care; the properties and actions of
Req. No. 12910 Page 6

1 drug s and dosage forms; and the etiology, characteristics, and
2 therapeutics of the diseased state;
3 10. “Dangerous drug”, “legend drug”, “prescription drug”, or
4 “Rx Only” means a drug:
5 a. for human use subject to 21 U.S.C., Section 353(b)(1),
6 or
7 b. is labeled “Prescription Only”, or labeled with the
8 following statement: “Caution: Federal law restricts
9 this drug except for to use by or on the order of a
10 licensed veterinarian.”;
11 11. “Director” means the Executive Director of the State Board
12 of Pharmacy unless context clearly indicates otherwise;
13 12. “Dispense” or “dispensing” means the interpretation,
14 evaluation, and implementation of a prescription drug order
15 including the preparation and delivery of a drug or device to a
16 patient or a patient’s agent in a suitable container appropriately
17 labeled for subsequent administration to, or use by, a patient.
18 Dispense includes sell, distribute, leave with, give away, dispose
19 of, deliver, or supply;
20 13. “Dispenser” means a retail pharmacy, hospital pharmacy, a
21 group of chain pharmacies under common ownership and control that do
22 not act as a wholesale distributor, or any other person authorized
23 by law to dispense or administer prescription drugs, and the
24 affiliated warehouses or distributions of such entities under common
Req. No. 12910 Page 7

1 owne rship and control that do not act as a wholesale distributor.
2 For the purposes of this paragraph, “dispenser” dispenser does not
3 mean a person who dispenses only products to be used in animals in
4 accordance with 21 U.S.C., Section 360b(a)(5);
5 14. “Distribute” or “distribution” means the sale, purchase,
6 trade, delivery, handling, storage, or receipt of a product, and
7 does not include the dispensing of a product pursuant to a
8 prescription executed in accordance with 21 U.S.C., Section
9 353(b)(1) or the dispensing of a product approved under 21 U.S.C.,
10 Section 360b(b); provided, taking actual physical possession of a
11 product or title shall not be required;
12 15. “Doctor of Pharmacy” means a person licensed by the Board
13 to engage in the practice of pharmacy. The terms “pharmacist”,
14 “D.Ph.”, and “Doctor of Pharmacy” shall be interchangeable and shall
15 have the same meaning wherever they appear in the Oklahoma Statutes
16 and the rules promulgated by the Board;
17 16. “Drug outlet” means all manufacturers, repackagers,
18 outsourcing facilities, wholesale distributors, third-party
19 logistics providers, pharmacies, and all other facilities which are
20 engaged in dispensing, delivery, distribution, or storage of
21 dangerous drugs;
22 17. “Drugs” means all medicinal substances and preparations
23 recognized by the United States Pharmacopoeia Pharmacopeia and
24 National Formulary, or any revision thereof, and all substances and
Req. No. 12910 Page 8

1 prep arations intended for external and/or internal use in the cure,
2 diagnosis, mitigation, treatment, or prevention of disease in humans
3 or animals and all substances and preparations, other than food,
4 intended to affect the structure or any function of the body of a
5 human or animals;
6 18. “Drug sample” means a unit of a prescription drug packaged
7 under the authority and responsibility of the manufacturer that is
8 not intended to be sold and is intended to promote the sale of the
9 drug;
10 19. “Durable medical equipment” has the same meaning as
11 provided by Section 2 of this act Section 375.2 of this title;
12 20. “Filled prescription” means a packaged prescription
13 medication to which a label has been affixed which contains such
14 information as is required by the Oklahoma Pharmacy Act;
15 21. “Hospital” means any institution licensed as a hospital by
16 this state for the care and treatment of patients, or a pharmacy
17 operated by the Oklahoma Department of Veterans Affairs;
18 22. “Licensed practitioner” means:
19 a. an allopathic physician,
20 b. an osteopathic physician,
21 c. a podiatric physician,
22 d. a dentist,
23 e. a veterinarian or,
24 f. an optometrist, or
Req. No. 12910 Page 9

1 g. an Advanced Practice Registered Nurse,
2 licensed to practice and authorized to prescribe dangerous drugs
3 within the scope of practice of such practitioner;
4 23. “Manufacturer” or “virtual manufacturer” means with respect
5 to a product:
6 a. a person that holds an application approved under 21
7 U.S.C., Section 355 or a license issued under 42
8 U.S.C., Section 262 for such product, or if such
9 product is not the subject of an approved application
10 or license, the person who manufactured the product,
11 b. a co-licensed partner of the person described in
12 subparagraph a of this paragraph that obtains the
13 product directly from a person described in this
14 subparagraph or subparagraph a of this paragraph,
15 c. an affiliate of a person described in subparagraph a
16 or b of this paragraph who receives the product
17 directly from a person described in this subparagraph
18 or in subparagraph a or b of this paragraph, or
19 d. a person who contracts with another to manufacture a
20 product;
21 24. “Manufacturing” means the production, preparation,
22 propagation, compounding, conversion, or processing of a device or a
23 drug, either directly or indirectly by extraction from substances of
24 natural origin or independently by means of chemical or biological
Req. No. 12910 Page 10

1 synt hesis and includes any packaging or repackaging of the
2 substances or labeling or relabeling of its container, and the
3 promotion and marketing of such drugs or devices. The term
4 “manufacturing” manufacturing also includes the preparation and
5 promotion of commercially available products from bulk compounds for
6 resale by licensed pharmacies, licensed practitioners, or other
7 persons;
8 25. “Medical gas” means those gases including those in liquid
9 state upon which the manufacturer or distributor has placed one of
10 several cautions, such as “Rx Only”, in compliance with federal law;
11 26. “Medical gas order” means an order for medical gas issued
12 by a licensed prescriber;
13 27. “Medical gas distributor” means a person licensed to
14 distribute, transfer, wholesale, deliver, or sell medical gases on
15 drug orders to suppliers or other entities licensed to use,
16 administer, or distribute medical gas and may also include a patient
17 or ultimate user;
18 28. “Medical gas supplier” means a person who dispenses medical
19 gases on drug orders only to a patient or ultimate user;
20 29. “Medicine” means any drug or combination of drugs which has
21 the property of curing, preventing, treating, diagnosing, or
22 mitigating diseases, or which is used for that purpose;
23 30. “Nonprescription drugs” means medicines or drugs which are
24 sold without a prescription and which are prepackaged for use by the
Req. No. 12910 Page 11

1 cons umer and labeled in accordance with the requirements of the
2 statutes and regulations of this state and the federal government.
3 Such items shall also include medical and dental supplies and
4 bottled or nonbulk chemicals which are sold or offered for sale to
5 the general public if such articles or preparations meet the
6 requirements of the Federal Food, Drug, and Cosmetic Act, 21
7 U.S.C.A., Section 321 et seq.;
8 31. “Outsourcing facility” including “virtual outsourcing
9 facility” means a facility at one geographic location or address
10 that:
11 a. is engaged in the compounding of sterile drugs,
12 b. has elected to register as an outsourcing facility,
13 and
14 c. complies with all requirements of 21 U.S.C., Section
15 353b;
16 32. “Package” means the smallest individual saleable unit of
17 product for distribution by a manufacturer or repackager that is
18 intended by the manufacturer for ultimate sale to the dispenser of
19 such product. For the purposes of this paragraph, “individual
20 saleable unit” means the smallest container of a product introduced
21 into commerce by the manufacturer or repackager that is intended by
22 the manufacturer or repackager for individual sale to a dispenser;
23
24
Req. No. 12910 Page 12

1 33. “Person” means an individual, partnership, limited
2 liability company, corporation, or association, unless the context
3 otherwise requires;
4 34. “Pharmacist-in-charge” or “PIC” means the pharmacist
5 licensed in this state responsible for the management control of a
6 pharmacy and all other aspects of the practice of pharmacy in a
7 licensed pharmacy as defined provided by Section 353.18 of this
8 title;
9 35. “Pharmacy” means a place regularly licensed by the State
10 Board of Pharmacy in which prescriptions, drugs, medicines,
11 chemicals, and poisons are compounded or dispensed or such place
12 where pharmacists practice the profession of pharmacy, or a pharmacy
13 operated by the Oklahoma Department of Veterans Affairs;
14 36. “Pharmacy technician”, “technician”, “Rx tech”, or “tech”
15 means a person issued a Technician technician permit by the State
16 Board of Pharmacy to assist the pharmacist and perform
17 nonjudgmental, technical, manipulative, non-discretionary functions
18 in the prescription department under the immediate and direct
19 supervision of a pharmacist;
20 37. “Poison” means any substance which when introduced into the
21 body, either directly or by absorption, produces violent, morbid, or
22 fatal changes, or which destroys living tissue with which such
23 substance comes into contact;
24 38. “Practice of pharmacy” means:
Req. No. 12910 Page 13

1 a. the interpretation and evaluation of prescription
2 orders,
3 b. the compounding, dispensing, administering, and
4 labeling of drugs and devices, except labeling by a
5 manufacturer, repackager, or distributor of
6 nonprescription drugs and commercially packaged legend
7 drugs and devices,
8 c. the participation in drug selection and drug
9 utilization reviews,
10 d. the proper and safe storage of drugs and devices and
11 the maintenance of proper records thereof,
12 e. the responsibility for advising by counseling and
13 providing information, where professionally necessary
14 or where regulated, of therapeutic values, content,
15 hazards, and use of drugs and devices,
16 f. the offering or performing of those acts, services,
17 operations, or transactions necessary in the conduct,
18 operation, management, and control of a pharmacy, or
19 g. the provision of those acts or services that are
20 necessary to provide pharmaceutical care;
21 39. “Preparation” means an article which may or may not contain
22 sterile products compounded in a licensed pharmacy pursuant to the
23 order of a licensed prescriber;
24
Req. No. 12910 Page 14

1 40. “Prescriber” means a person licensed in this state who is
2 authorized to prescribe dangerous drugs within the scope of practice
3 of the person’s profession;
4 41. “Prescription” means and includes any order for drug or
5 medical supplies written or signed, or transmitted by word of mouth,
6 telephone, or other means of communication:
7 a. by a licensed prescriber,
8 b. under the supervision of an Oklahoma licensed
9 practitioner, an Oklahoma licensed advanced practice
10 registered nurse or an Oklahoma licensed by a
11 physician assistant pursuant to a practice agreement,
12 or
13 c. (1) under the supervision of a supervising physician,
14 by a Certified Nurse Practitioner, Clinical Nurse
15 Specialist, or Certified Nurse-Midwife licensed
16 in this state who has not obtained independent
17 prescriptive authority under Section 1 of this
18 act, or
19 (2) by a Certified Nurse Practitioner, Clinical Nurse
20 Specialist, or Certified Nurse-Midwife licensed
21 in this state who has obtained independent
22 prescriptive authority under Section 1 of this
23 act, or
24
Req. No. 12910 Page 15

1 d. by an Oklahoma licensed wholesaler or distributor as
2 authorized in Section 353.29.1 of this title;
3 42. “Product” means a prescription drug in a finished dosage
4 form for administration to a patient without substantial further
5 manufacturing, such as capsules, tablets, and lyophilized products
6 before reconstitution. “Product” Product does not include blood
7 components intended for transfusion, radioactive drugs or biologics
8 and medical gas;
9 43. “Repackager”, including “virtual repackager”, means a
10 person who owns or operates an establishment that repacks and
11 relabels a product or package for further sale or distribution
12 without further transaction;
13 44. “Sterile drug” means a drug that is intended for parenteral
14 administration, an ophthalmic or oral inhalation drug in aqueous
15 format, or a drug that is required to be sterile under state and
16 federal law;
17 45. “Supervising physician” means an individual holding a
18 current license to practice as a physician from the State Board of
19 Medical Licensure and Supervision, pursuant to the provisions of the
20 Oklahoma Allopathic Medical and Surgical Licensure and Supervision
21 Act, or the State Board of Osteopathic Examiners, pursuant to the
22 provisions of the Oklahoma Osteopathic Medicine Act, who supervises
23 an advanced practice registered nurse a Certified Nurse
24 Practitioner, Clinical Nurse Specialist, or Certified Nurse-Midwife
Req. No. 12910 Page 16

1 as d efined in Section 567.3a of this title who has not obtained
2 independent prescriptive authority under Section 1 of this act,
3 and who is not in training as an intern, resident, or fellow. To be
4 eligible to supervise an advanced practice registered nurse, such
5 The supervising physician shall remain in compliance with the rules
6 promulgated by the State Board of Medical Licensure and Supervision
7 or the State Board of Osteopathic Examiners;
8 46. “Supportive personnel” means technicians and auxiliary
9 supportive persons who are regularly paid employees of a pharmacy
10 who work and perform tasks in the pharmacy as authorized by Section
11 353.18A of this title;
12 47. “Third-party logistics provider” including “virtual third-
13 party logistics provider” means an entity that provides or
14 coordinates warehousing, or other logistics services of a product in
15 interstate commerce on behalf of a manufacturer, wholesale
16 distributor, or dispenser of a product but does not take ownership
17 of the product, nor have responsibility to direct the sale or
18 disposition of the product. For the purposes of this paragraph,
19 “third-party logistics provider” third-party logistics provider does
20 not include shippers and the United States Postal Service;
21 48. “Wholesale distributor” including “virtual wholesale
22 distributor” means a person other than a manufacturer, a
23 manufacturer’s co-licensed partner, a third-party logistics
24 provider, or repackager engaged in wholesale distribution as defined
Req. No. 12910 Page 17

1 by 2 1 U.S.C., Section 353(e)(4) as amended by the Drug Supply Chain
2 Security Act;
3 49. “County jail” means a facility operated by a county for the
4 physical detention and correction of persons charged with, or
5 convicted of, criminal offenses or ordinance violations or persons
6 found guilty of civil or criminal contempt;
7 50. “State correctional facility” means a facility or
8 institution that houses a prisoner population under the jurisdiction
9 of the Department of Corrections;
10 51. “Unit dose package” means a package that contains a single
11 dose drug with the name, strength, control number, and expiration
12 date of that drug on the label; and
13 52. “Unit of issue package” means a package that provides
14 multiple doses of the same drug, but each drug is individually
15 separated and includes the name, lot number, and expiration date.
16 SECTION 6. AMENDATORY 59 O.S. 2021, Section 353.1a, is
17 amended to read as follows:
18 Section 353.1a. A. Prescribing 1. Prescriptive authority
19 shall be allowed, under the medical direction of a current
20 supervision agreement with a supervising physician, for an advanced
21 practice nurse a licensed Advanced Practice Registered Nurse
22 recognized by the Oklahoma Board of Nursing in one of the following
23 categories: advanced registered nurse practitioners, clinical nurse
24 specialists, or certified nurse-midwives as a Certified Nurse
Req. No. 12910 Page 18

1 Prac titioner, Clinical Nurse Specialist, or Certified Nurse-Midwife
2 who has not obtained independent prescriptive authority under
3 Section 1 of this act.
4 2. Prescriptive authority shall be allowed, independent of a
5 current supervision agreement with a supervising physician, for a
6 licensed Advanced Practice Registered Nurse recognized by the
7 Oklahoma Board of Nursing as a Certified Nurse Practitioner,
8 Clinical Nurse Specialist, or Certified Nurse-Midwife who has
9 obtained independent prescriptive authority under Section 1 of this
10 act.
11 B. The advanced practice nurse Advanced Practice Registered
12 Nurse may write or sign, or transmit by word of mouth, telephone, or
13 other means of communication an order for drugs or medical supplies
14 that is intended to be filled, compounded, or dispensed by a
15 pharmacist. The supervising physician, if applicable, and the
16 advanced practice nurse prescribing Advanced Practice Registered
17 Nurse shall be identified at the time of origination of the
18 prescription and the name of the advanced practice nurse prescribing
19 Advanced Practice Registered Nurse shall be printed on the
20 prescription label.
21 B. C. Pharmacists may dispense prescriptions for non-controlled
22 prescription drugs authorized by an advanced practice nurse Advanced
23 Practice Registered Nurse or physician assistant, not located in
24
Req. No. 12910 Page 19

1 Okla homa this state, provided that they are licensed in the state in
2 which they are actively prescribing.
3 C. D. 1. Pharmacists may only dispense prescriptions for
4 controlled dangerous substances prescribed by an advanced practice
5 nurse or physician assistant Advanced Practice Registered Nurse
6 licensed in the State of Oklahoma and supervised by an Oklahoma-
7 licensed practitioner this state who meets the criteria in paragraph
8 1 or 2 of subsection A of this section.
9 2. Pharmacists may only dispense prescriptions for controlled
10 dangerous substances prescribed by a physician assistant licensed in
11 this state pursuant to a practice agreement.
12 SECTION 7. AMENDATORY 59 O.S. 2021, Section 567.3a, is
13 amended to read as follows:
14 Section 567.3a. As used in the Oklahoma Nursing Practice Act:
15 1. “Board” means the Oklahoma Board of Nursing;
16 2. “The practice of nursing” means the performance of services
17 provided for purposes of nursing diagnosis and treatment of human
18 responses to actual or potential health problems consistent with
19 educational preparation. Knowledge and skill are the basis for
20 assessment, analysis, planning, intervention, and evaluation used in
21 the promotion and maintenance of health and nursing management of
22 illness, injury, infirmity, restoration or of optimal function, or
23 death with dignity. Practice is based on understanding the human
24 condition across the human lifespan and understanding the
Req. No. 12910 Page 20

1 rela tionship of the individual within the environment. This
2 practice includes execution of the medical regime including the
3 administration of medications and treatments prescribed by any
4 person authorized by state law to so prescribe;
5 3. “Registered nursing” means the practice of the full scope of
6 nursing which includes, but is not limited to:
7 a. assessing the health status of individuals, families,
8 and groups,
9 b. analyzing assessment data to determine nursing care
10 needs,
11 c. establishing goals to meet identified health care
12 needs,
13 d. planning a strategy of care,
14 e. establishing priorities of nursing intervention to
15 implement the strategy of care,
16 f. implementing the strategy of care,
17 g. delegating such tasks as may safely be performed by
18 others, consistent with educational preparation and
19 that do not conflict with the provisions of the
20 Oklahoma Nursing Practice Act,
21 h. providing safe and effective nursing care rendered
22 directly or indirectly,
23 i. evaluating responses to interventions,
24 j. teaching the principles and practice of nursing,
Req. No. 12910 Page 21

1 k. managing and supervising the practice of nursing,
2 l. collaborating with other health professionals in the
3 management of health care,
4 m. performing additional nursing functions in accordance
5 with knowledge and skills acquired beyond basic
6 nursing preparation, and
7 n. delegating those nursing tasks as defined in the rules
8 of the Board that may be performed by an advanced
9 unlicensed assistive person Advanced Unlicensed
10 Assistant;
11 4. “Licensed practical nursing” means the practice of nursing
12 under the supervision or direction of a registered nurse Registered
13 Nurse, licensed physician, or dentist. This directed scope of
14 nursing practice includes, but is not limited to:
15 a. contributing to the assessment of the health status of
16 individuals and groups,
17 b. participating in the development and modification of
18 the plan of care,
19 c. implementing the appropriate aspects of the plan of
20 care,
21 d. delegating such tasks as may safely be performed by
22 others, consistent with educational preparation and
23 that do not conflict with the Oklahoma Nursing
24 Practice Act,
Req. No. 12910 Page 22

1 e. providing safe and effective nursing care rendered
2 directly or indirectly,
3 f. participating in the evaluation of responses to
4 interventions,
5 g. teaching basic nursing skills and related principles,
6 h. performing additional nursing procedures in accordance
7 with knowledge and skills acquired through education
8 beyond nursing preparation, and
9 i. delegating those nursing tasks as defined in the rules
10 of the Board that may be performed by an advanced
11 unlicensed assistive person Advanced Unlicensed
12 Assistant;
13 5. “Advanced Practice Registered Nurse” means a licensed
14 Registered Nurse:
15 a. who has completed an advanced practice registered
16 nursing education program in preparation for one of
17 four recognized advanced practice registered nurse
18 Advanced Practice Registered Nurse roles,
19 b. who has passed a national certification examination
20 recognized by the Board that measures the advanced
21 practice registered nurse Advanced Practice Registered
22 Nurse role and specialty competencies and who
23 maintains recertification in the role and specialty
24 through a national certification program,
Req. No. 12910 Page 23

1 c. who has acquired advanced clinical knowledge and
2 skills in preparation for providing both direct and
3 indirect care to patients; however, the defining
4 factor for all Advanced Practice Registered Nurses is
5 that a significant component of the education and
6 practice focuses on direct care of individuals,
7 d. whose practice builds on the competencies of
8 Registered Nurses by demonstrating a greater depth and
9 breadth of knowledge, a greater synthesis of data, and
10 increased complexity of skills and interventions, and
11 e. who has obtained a license as an Advanced Practice
12 Registered Nurse in one of the following roles:
13 Certified Registered Nurse Anesthetist, Certified
14 Nurse-Midwife, Clinical Nurse Specialist, or Certified
15 Nurse Practitioner.
16 Only those persons who hold a license to practice advanced
17 practice registered nursing in this state shall have the right to
18 use the title “Advanced Practice Registered Nurse” Advanced Practice
19 Registered Nurse and to use the abbreviation “APRN”. Only those
20 persons who have obtained a license in the following disciplines
21 shall have the right to fulfill the roles and use the applicable
22 titles: Certified Registered Nurse Anesthetist and the abbreviation
23 “CRNA”, Certified Nurse-Midwife and the abbreviation “CNM”, Clinical
24
Req. No. 12910 Page 24

1 Nurs e Specialist and the abbreviation “CNS”, and Certified Nurse
2 Practitioner and the abbreviation “CNP”.
3 It shall be unlawful for any person to assume the role or use
4 the title Advanced Practice Registered Nurse or use the abbreviation
5 “APRN” APRN or use the respective specialty role titles and
6 abbreviations or to use any other titles or abbreviations that would
7 reasonably lead a person to believe the user is an Advanced Practice
8 Registered Nurse, unless permitted by the Oklahoma Nursing Practice
9 Act. Any individual doing so shall be guilty of a misdemeanor,
10 which shall be punishable, upon conviction, by imprisonment in the
11 county jail for not more than one (1) year or by a fine of not less
12 than One Hundred Dollars ($100.00) nor more than One Thousand
13 Dollars ($1,000.00), or by both such imprisonment and fine for each
14 offense;
15 6. “Certified Nurse Practitioner” is means an Advanced Practice
16 Registered Nurse who performs in an expanded role in the delivery of
17 health care:
18 a. consistent with advanced educational preparation as a
19 Certified Nurse Practitioner in an area of specialty,
20 b. functions within the Certified Nurse Practitioner
21 scope of practice for the selected area of
22 specialization, and
23
24
Req. No. 12910 Page 25

1 c. is in accord with the standards for Certified Nurse
2 Practitioners as identified by the certifying body and
3 approved by the Board.
4 A Certified Nurse Practitioner shall be eligible, in accordance
5 with the scope of practice of the Certified Nurse Practitioner, to
6 obtain recognition as authorized by the Board to prescribe, as
7 defined by the rules promulgated by the Board pursuant to this
8 section and subject to the medical direction of a supervising
9 physician Section 567.4a of this title and Section 1 of this act.
10 This authorization shall not include dispensing drugs, but shall not
11 preclude, subject to federal regulations, the receipt of, the
12 signing for, or the dispensing of professional samples to patients.
13 The Certified Nurse Practitioner accepts responsibility,
14 accountability, and obligation to practice in accordance with usual
15 and customary advanced practice registered nursing standards and
16 functions as defined by the scope of practice/role definition
17 statements for the Certified Nurse Practitioner;
18 7. a. “Clinical Nurse Specialist” is means an Advanced
19 Practice Registered Nurse who holds:
20 (1) a master’s degree or higher in nursing with
21 clinical specialization preparation to function
22 in an expanded role,
23
24
Req. No. 12910 Page 26

1 (2) specialty certification from a national
2 certifying organization recognized by the Board,
3 and
4 (3) an Advanced Practice Registered Nurse license
5 from the Board, and.
6 (4) any
7 Any nurse holding a specialty certification as a
8 Clinical Nurse Specialist valid on January 1, 1994,
9 granted by a national certifying organization
10 recognized by the Board, shall be deemed to be a
11 Clinical Nurse Specialist under the provisions of the
12 Oklahoma Nursing Practice Act.
13 b. In the expanded role, the Clinical Nurse Specialist
14 performs at an advanced practice level which shall
15 include, but not be limited to:
16 (1) practicing as an expert clinician in the
17 provision of direct nursing care to a selected
18 population of patients or clients in any setting,
19 including private practice,
20 (2) managing the care of patients or clients with
21 complex nursing problems,
22 (3) enhancing patient or client care by integrating
23 the competencies of clinical practice, education,
24 consultation, and research, and
Req. No. 12910 Page 27

1 (4) referring patients or clients to other services.
2 c. A Clinical Nurse Specialist in accordance with the
3 scope of practice of such Clinical Nurse Specialist
4 shall be eligible to obtain recognition as authorized
5 by the Board to prescribe, as defined by the rules
6 promulgated by the Board pursuant to this section, and
7 subject to the medical direction of a supervising
8 physician Section 567.4a of this title and Section 1
9 of this act. This authorization shall not include
10 dispensing drugs, but shall not preclude, subject to
11 federal regulations, the receipt of, the signing for,
12 or the dispensing of professional samples to patients.
13 d. The Clinical Nurse Specialist accepts responsibility,
14 accountability, and obligation to practice in
15 accordance with usual and customary advanced practice
16 nursing standards and functions as defined by the
17 scope of practice/role definition statements for the
18 Clinical Nurse Specialist;
19 8. “Nurse-Midwife” is “Certified Nurse-Midwife” means a nurse
20 who has received an Advanced Practice Registered Nurse license from
21 the Oklahoma Board of Nursing who possesses evidence of
22 certification according to the requirements of the American College
23 of Nurse-Midwives.
24
Req. No. 12910 Page 28

1 A Certified Nurse-Midwife in accordance with the scope of
2 practice of such Certified Nurse-Midwife shall be eligible to obtain
3 recognition as authorized by the Board to prescribe, as defined by
4 the rules promulgated by the Board pursuant to this section and
5 subject to the medical direction of a supervising physician Section
6 567.4a of this title and Section 1 of this act. This authorization
7 shall not include the dispensing of drugs, but shall not preclude,
8 subject to federal regulations, the receipt of, the signing for, or
9 the dispensing of professional samples to patients.
10 The Certified Nurse-Midwife accepts responsibility,
11 accountability, and obligation to practice in accordance with usual
12 and customary advanced practice registered nursing standards and
13 functions as defined by the scope of practice/role definition
14 statements for the Certified Nurse-Midwife;
15 9. “Nurse-midwifery practice” means providing management of
16 care of normal newborns and women, antepartally, intrapartally,
17 postpartally, and gynecologically, occurring within a health care
18 system which provides for medical consultation, medical management,
19 or referral, and is in accord with the standards for nurse-midwifery
20 practice as defined by the American College of Nurse-Midwives;
21 10. a. “Certified Registered Nurse Anesthetist” is means an
22 Advanced Practice Registered Nurse who:
23 (1) is certified by the National Board of
24 Certification and Recertification for Nurse
Req. No. 12910 Page 29

1 Anesthetists as a Certified Registered Nurse
2 Anesthetist within one (1) year following
3 completion of an approved certified registered
4 nurse anesthetist Certified Registered Nurse
5 Anesthetist education program, and continues to
6 maintain such recertification by the National
7 Board of Certification and Recertification for
8 Nurse Anesthetists, and
9 (2) administers anesthesia in collaboration with a
10 medical doctor, an osteopathic physician, a
11 podiatric physician, or a dentist licensed in
12 this state and under conditions in which timely
13 onsite on-site consultation by such doctor,
14 osteopath, podiatric physician, or dentist is
15 available.
16 b. A Certified Registered Nurse Anesthetist, in
17 collaboration with a medical doctor, osteopathic
18 physician, podiatric physician, or dentist licensed in
19 this state, and under conditions in which timely, on-
20 site consultation by such medical doctor, osteopathic
21 physician, podiatric physician, or dentist is
22 available, shall be authorized, pursuant to rules
23 adopted by the Oklahoma Board of Nursing, to order,
24 select, obtain, and administer legend drugs, Schedules
Req. No. 12910 Page 30

1 II through V controlled substances, devices, and
2 medical gases only when engaged in the preanesthetic
3 preparation and evaluation; anesthesia induction,
4 maintenance, and emergence; and postanesthesia care.
5 A Certified Registered Nurse Anesthetist may order,
6 select, obtain, and administer drugs only during the
7 perioperative or periobstetrical period.
8 c. A Certified Registered Nurse Anesthetist who applies
9 for authorization to order, select, obtain, and
10 administer drugs shall:
11 (1) be currently recognized as a Certified Registered
12 Nurse Anesthetist in this state,
13 (2) provide evidence of completion, within the two-
14 year period immediately preceding the date of
15 application, of a minimum of fifteen (15) units
16 of continuing education in advanced pharmacology
17 related to the administration of anesthesia as
18 recognized by the National Board of Certification
19 and Recertification for Nurse Anesthetists, and
20 (3) complete and submit a notarized application, on a
21 form prescribed by the Board, accompanied by the
22 application fee established pursuant to this
23 section.
24
Req. No. 12910 Page 31

1 d. The authority to order, select, obtain, and administer
2 drugs shall be terminated if a Certified Registered
3 Nurse Anesthetist has:
4 (1) ordered, selected, obtained, or administered
5 drugs outside of the Certified Registered Nurse
6 Anesthetist scope of practice or ordered,
7 selected, obtained, or administered drugs for
8 other than therapeutic purposes, or
9 (2) violated any provision of state laws or rules or
10 federal laws or regulations pertaining to the
11 practice of nursing or the authority to order,
12 select, obtain, and administer drugs.
13 e. The Oklahoma Board of Nursing shall notify the State
14 Board of Pharmacy after termination of or a change in
15 the authority to order, select, obtain, and administer
16 drugs for a Certified Registered Nurse Anesthetist.
17 f. The Board shall provide by rule for biennial
18 application renewal and reauthorization of authority
19 to order, select, obtain, and administer drugs for
20 Certified Registered Nurse Anesthetists. At the time
21 of application renewal, a Certified Registered Nurse
22 Anesthetist shall submit documentation of a minimum of
23 eight (8) units of continuing education, completed
24 during the previous two (2) years, in advanced
Req. No. 12910 Page 32

1 pharmacology relating to the administration of
2 anesthesia, as recognized by the Council on
3 Recertification of Nurse Anesthetists or the Council
4 on Certification of Nurse Anesthetists National Board
5 of Certification and Recertification for Nurse
6 Anesthetists.
7 g. This paragraph shall not prohibit the administration
8 of local or topical anesthetics as now permitted by
9 law. Provided further, nothing in this paragraph
10 shall limit the authority of the Board of Dentistry to
11 establish the qualifications for dentists who direct
12 the administration of anesthesia.
13 h. As used in this paragraph, “collaboration” means an
14 agreement between a medical doctor, osteopathic
15 physician, podiatric physician, or dentist performing
16 the procedure or directly involved with the procedure
17 and the Certified Registered Nurse Anesthetist working
18 jointly toward a common goal providing services for
19 the same patient. This collaboration involves the
20 joint formulation, discussion, and agreement of the
21 anesthesia plan by both parties, and the collaborating
22 medical doctor, osteopathic physician, podiatric
23 physician, or dentist performing the procedure or
24 directly involved with the procedure and that
Req. No. 12910 Page 33

1 collaborating physician shall remain available for
2 timely onsite on-site consultation during the delivery
3 of anesthesia for diagnosis, consultation, and
4 treatment of medical conditions;
5 11. “Supervising physician” means an individual holding a
6 current license to practice as a physician from the State Board of
7 Medical Licensure and Supervision or the State Board of Osteopathic
8 Examiners, who supervises a Certified Nurse Practitioner, a Clinical
9 Nurse Specialist, or a Certified Nurse-Midwife who has not obtained
10 independent prescriptive authority under Section 1 of this act, and
11 who is not in training as an intern, resident, or fellow. To be
12 eligible to supervise such Advanced Practice Registered Nurse, such
13 The supervising physician shall remain in compliance with the rules
14 promulgated by the State Board of Medical Licensure and Supervision
15 or the State Board of Osteopathic Examiners;
16 12. “Supervision of an Advanced Practice Registered Nurse with
17 prescriptive authority” means overseeing and accepting
18 responsibility for the ordering and transmission by assuring
19 availability of the supervising physician to a Certified Nurse
20 Practitioner, a Clinical Nurse Specialist, or a Certified Nurse-
21 Midwife of who has not obtained independent prescriptive authority
22 under Section 1 of this act through direct contact,
23 telecommunications, or other appropriate electronic means for
24 consultation, assistance with medical emergencies, or patient
Req. No. 12910 Page 34

1 refe rral with respect to written, telephonic, electronic, or oral
2 prescriptions for drugs and other medical supplies, subject to a
3 defined formulary; and
4 13. “Advanced Unlicensed Assistant” means any person who has
5 successfully completed a certified training program approved by the
6 Board that trains the Advanced Unlicensed Assistant to perform
7 specified technical skills identified by the Board in acute care
8 settings under the direction and supervision of the Registered Nurse
9 or Licensed Practical Nurse.
10 SECTION 8. AMENDATORY 59 O.S. 2021, Section 567.4a, is
11 amended to read as follows:
12 Section 567.4a. The Oklahoma Board of Nursing may grant
13 prescriptive authority through the Advanced Practice Registered
14 Nurse license to Certified Nurse Practitioners, Clinical Nurse
15 Specialists, and Certified Nurse-Midwives who meet the requirements
16 for prescriptive authority identified by law and in the Board’s
17 rules. The rules regarding prescriptive authority recognition
18 promulgated by the Oklahoma Board of Nursing pursuant to paragraphs
19 6 through 9, 11 and 12 of this section, Section 567.3a of this
20 title, and Section 1 of this act shall:
21 1. Define the procedure for documenting supervision by a
22 supervising physician licensed in Oklahoma to practice by the State
23 Board of Medical Licensure and Supervision or the State Board of
24 Osteopathic Examiners, as defined in Section 567.3a of this title,
Req. No. 12910 Page 35

1 of a Certified Nurse Practitioner, Clinical Nurse Specialist, or
2 Certified Nurse-Midwife who has not obtained independent
3 prescriptive authority under Section 1 of this act. Such procedure
4 shall include a written statement that defines appropriate referral,
5 consultation, and collaboration between the Advanced Practice
6 Registered Nurse, recognized to prescribe as defined in paragraphs 6
7 through 9, 11 and 12 of Section 567.3a of this title, and the
8 supervising physician. The written statement shall include a method
9 of assuring availability of the supervising physician through direct
10 contact, telecommunications, or other appropriate electronic means
11 for consultation, assistance with medical emergencies, or patient
12 referral. The written statement shall be part of the initial
13 application and the renewal application submitted to the Board for
14 recognition for prescriptive authority for the Advanced Practice
15 Registered Nurse. Changes to the written statement shall be filed
16 with the Board within thirty (30) days of the change and shall be
17 effective on filing;
18 2. Define the procedure for documenting independent
19 prescriptive authority for Certified Nurse Practitioners, Clinical
20 Nurse Specialists, and Certified Nurse-Midwives who have obtained
21 independent prescriptive authority under Section 1 of this act;
22 3. Define minimal requirements for initial application for
23 prescriptive authority which shall include, but not be limited to,
24 evidence of completion of a minimum of forty-five (45) contact hours
Req. No. 12910 Page 36

1 or t hree (3) academic credit hours of education in
2 pharmacotherapeutics, clinical application, and use of
3 pharmacological agents in the prevention of illness, and in the
4 restoration and maintenance of health in a program beyond basic
5 registered nurse preparation, approved by the Board. Such contact
6 hours or academic credits shall be obtained within a time period of
7 three (3) years immediately preceding the date of application for
8 prescriptive authority;
9 3. 4. Define minimal requirements for application for renewal
10 of prescriptive authority which shall include, but not be limited
11 to, documentation of a minimum of:
12 a. fifteen (15) contact hours or one (1) academic credit
13 hour of education in pharmacotherapeutics, clinical
14 application, and use of pharmacological agents in the
15 prevention of illness, and in the restoration and
16 maintenance of health in a program beyond basic
17 registered nurse preparation, and
18 b. two (2) hours of education in pain management or two
19 (2) hours of education in opioid use or addiction,
20 unless the Advanced Practice Registered Nurse has
21 demonstrated to the satisfaction of the Board that the
22 Advanced Practice Registered Nurse does not currently
23 hold a valid federal Drug Enforcement Administration
24 registration number,
Req. No. 12910 Page 37

1 appr oved by the Board, within the two-year period immediately
2 preceding the effective date of application for renewal of
3 prescriptive authority;
4 4. 5. Require that beginning July 1, 2002, an Advanced Practice
5 Registered Nurse shall demonstrate demonstrates successful
6 completion of a master’s degree or higher in a clinical nurse
7 specialty one of the following Advanced Practice Registered Nurse
8 roles:
9 a. Certified Nurse Practitioner,
10 b. Clinical Nurse Specialist, or
11 c. Certified Nurse-Midwife,
12 in order to be eligible for initial application for prescriptive
13 authority under the provisions of the Oklahoma Nursing Practice Act;
14 5. 6. Define the method for communicating authority to
15 prescribe or termination of same, and the formulary to the State
16 Board of Pharmacy, all pharmacies, and all registered pharmacists;
17 6. 7. Define terminology used in such rules;
18 7. 8. Define the parameters for the prescribing practices of
19 the Advanced Practice Registered Nurse;
20 8. 9. Define the methods for termination of prescriptive
21 authority for the Advanced Practice Registered Nurse; and
22 9.
23 10. a. Establish a Formulary Advisory Council that shall
24 develop and submit to the Board recommendations for an
Req. No. 12910 Page 38

1 exclusionary formulary that shall list drugs or
2 categories of drugs that shall not be prescribed by an
3 Advanced Practice Registered Nurse recognized to
4 prescribe by the Oklahoma Board of Nursing. The
5 Formulary Advisory Council shall also develop and
6 submit to the Board recommendations for practice-
7 specific prescriptive standards for each category of
8 Advanced Practice Registered Nurse recognized to
9 prescribe by the Oklahoma Board of Nursing pursuant to
10 the provisions of the Oklahoma Nursing Practice Act.
11 The Board shall either accept or reject the
12 recommendations made by the Council. No amendments to
13 the recommended exclusionary formulary may be made by
14 the Board without the approval of the Formulary
15 Advisory Council.
16 b. In addition to the other powers and duties of the
17 Formulary Advisory Council prescribed by this
18 paragraph, the Formulary Advisory Council shall
19 develop guidelines for supervising physicians on best
20 practices for the supervision of Advanced Practice
21 Registered Nurses who have not obtained independent
22 prescriptive authority. The supervision guidelines
23 shall be published on the Board’s website and the
24
Req. No. 12910 Page 39

1 Formulary Advisory Council shall periodically update
2 the guidelines as necessary.
3 c. The Formulary Advisory Council shall be composed of
4 twelve (12) members as follows:
5 (1) four members, to include a pediatrician, an
6 obstetrician-gynecological physician, a general
7 internist, and a family practice physician;
8 provided, that three of such members shall be
9 appointed by the Oklahoma State Medical
10 Association, and one shall be appointed by the
11 Oklahoma Osteopathic Association,
12 (2) four members who are registered pharmacists,
13 appointed by the Oklahoma Pharmaceutical
14 Pharmacists Association, and
15 (3) four members, one of whom shall be a Certified
16 Nurse Practitioner, one of whom shall be a
17 Clinical Nurse Specialist, one of whom shall be a
18 Certified Nurse-Midwife, and one of whom shall be
19 a current member of the Oklahoma Board of
20 Nursing, all of whom shall be appointed by the
21 Oklahoma Board of Nursing.
22 c.
23 d. All professional members of the Formulary Advisory
24 Council shall be in active clinical practice, at least
Req. No. 12910 Page 40

1 fifty percent (50%) of the time, within their defined
2 area of specialty. The members of the Formulary
3 Advisory Council shall serve at the pleasure of the
4 appointing authority for a term of three (3) years.
5 The terms of the members shall be staggered. Members
6 of the Council may serve beyond the expiration of
7 their term of office until a successor is appointed by
8 the original appointing authority. A vacancy on the
9 Council shall be filled for the balance of the
10 unexpired term by the original appointing authority.
11 d.
12 e. Members of the Council shall elect a chair and a vice-
13 chair vice chair from among the membership of the
14 Council. For the transaction of business, at least
15 seven members, with a minimum of two members present
16 from each of the identified categories of physicians,
17 pharmacists, and advanced practice registered nurses
18 Advanced Practice Registered Nurses, shall constitute
19 a quorum. The Council shall recommend and the Board
20 shall approve and implement an initial exclusionary
21 formulary on or before January 1, 1997. The Council
22 and the Board shall annually review the approved
23 exclusionary formulary and shall make any necessary
24
Req. No. 12910 Page 41

1 revisions utilizing the same procedures used to
2 develop the initial exclusionary formulary.
3 SECTION 9. AMENDATORY 59 O.S. 2021, Section 567.5a, as
4 amended by Section 1, Chapter 94, O.S.L. 2024 (59 O.S. Supp. 2024,
5 Section 567.5a), is amended to read as follows:
6 Section 567.5a. A. All applicants for a license to practice as
7 an Advanced Practice Registered Nurse shall be subject to Section
8 567.8 of this title.
9 B. An applicant for an initial license to practice as an
10 Advanced Practice Registered Nurse shall:
11 1. Submit a completed written application and appropriate fees
12 as established by the Oklahoma Board of Nursing;
13 2. Submit a criminal history records check that complies with
14 Section 567.18 of this title;
15 3. Hold a current Registered Nurse license in this state;
16 4. Have completed an advanced practice registered nursing
17 education program in one of the four advanced practice registered
18 nurse Advanced Practice Registered Nurse roles and a specialty area
19 recognized by the Board. Effective January 1, 2016, the applicant
20 shall have completed an accredited graduate level advanced practice
21 registered nursing education program in at least one of the
22 following population foci: family/individual across the lifespan,
23 adult-gerontology, neonatal, pediatrics, women’s health/gender-
24 related, or psychiatric/mental health;
Req. No. 12910 Page 42

1 5. Be currently certified in an advanced practice specialty
2 certification consistent with educational preparation and by a
3 national certifying body recognized by the Board; and
4 6. Provide any and all other evidence as required by the Board
5 in its rules.
6 C. The Board may issue a license by endorsement to an Advanced
7 Practice Registered Nurse licensed under the laws of another state
8 if the applicant meets the qualifications for licensure in this
9 state. An applicant by endorsement shall:
10 1. Submit a completed written application and appropriate fees
11 as established by the Board;
12 2. Submit a criminal history records check that complies with
13 Section 567.18 of this title;
14 3. Hold a current Registered Nurse license in this state;
15 4. Hold recognition as an Advanced Practice Registered Nurse in
16 a state or territory;
17 5. Have completed an advanced practice registered nursing
18 education program in one of the four roles and a specialty area
19 recognized by the Board. Effective January 1, 2016, the applicant
20 shall have completed an accredited graduate level advanced practice
21 registered nursing education program in at least one of the
22 following population foci: family/individual across the lifespan,
23 adult-gerontology, neonatal, pediatrics, women’s health/gender-
24 related, or psychiatric/mental health;
Req. No. 12910 Page 43

1 6. Be currently certified in an advanced practice specialty
2 certification consistent with educational preparation and by a
3 national certifying body recognized by the Board;
4 7. Meet continued competency requirements as set forth in Board
5 rules; and
6 8. Provide any and all other evidence as required by the Board
7 in its rules.
8 D. The Board may issue prescriptive authority recognition by
9 endorsement to an Advanced Practice Registered Nurse licensed as an
10 APRN-CNP Advanced Practice Registered Nurse-Certified Nurse
11 Practitioner (APRN-CNP), APRN-CNS Advanced Practice Registered
12 Nurse-Clinical Nurse Specialist (APRN-CNS), or APRN-CNM Advanced
13 Practice Registered Nurse-Certified Nurse-Midwife (APRN-CNM) under
14 the laws of another state if the applicant meets the requirements
15 set forth in this section. An applicant for prescriptive authority
16 recognition by endorsement shall:
17 1. Submit a completed written application and appropriate fees
18 as established by the Board;
19 2. Hold current Registered Nurse and Advanced Practice
20 Registered Nurse licenses (APRN-CNP, APRN-CNS, or APRN-CNM) in the
21 state;
22 3. Hold current licensure or recognition as an Advanced
23 Practice Registered Nurse in the same role and specialty with
24 prescribing privileges in another state or territory;
Req. No. 12910 Page 44

1 4. Submit documentation verifying successful completion of a
2 graduate level graduate-level advanced practice registered nursing
3 education program that included an academic course in
4 pharmacotherapeutic management, and didactic and clinical
5 preparation for prescribing incorporated throughout the program;
6 5. Submit a written statement from an Oklahoma licensed
7 physician supervising prescriptive authority as required by the
8 Board in its rules, or submit documentation that the applicant meets
9 the requirements for independent prescriptive authority under
10 Section 1 of this act;
11 6. Meet continued competency requirements as set forth in Board
12 rules; and
13 7. Provide any and all other evidence as required by the Board
14 in its rules.
15 E. An Advanced Practice Registered Nurse license issued under
16 this section shall be renewed concurrently with the registered nurse
17 Registered Nurse license, provided that qualifying criteria continue
18 to be met.
19 F. The Board may reinstate a license as set forth in Board
20 rules.
21 SECTION 10. AMENDATORY 63 O.S. 2021, Section 2-312, as
22 amended by Section 2, Chapter 184, O.S.L. 2022 (63 O.S. Supp. 2024,
23 Section 2-312), is amended to read as follows:
24
Req. No. 12910 Page 45

1 Section 2-312. A. A physician, podiatrist, optometrist, or a
2 dentist who has complied with the registration requirements of the
3 Uniform Controlled Dangerous Substances Act, in good faith and in
4 the course of such person’s professional practice only, may
5 prescribe and administer controlled dangerous substances, or may
6 cause the same to be administered by medical or paramedical
7 personnel acting under the direction and supervision of the
8 physician, podiatrist, optometrist, or dentist, and only may
9 dispense controlled dangerous substances pursuant to the provisions
10 of Sections 355.1 and 355.2 of Title 59 of the Oklahoma Statutes.
11 B. A veterinarian who has complied with the registration
12 requirements of the Uniform Controlled Dangerous Substances Act, in
13 good faith and in the course of the professional practice of the
14 veterinarian only, and not for use by a human being, may prescribe,
15 administer, and dispense controlled dangerous substances and may
16 cause them to be administered by an assistant or orderly under the
17 direction and supervision of the veterinarian.
18 C. 1. An advanced practice nurse Advanced Practice Registered
19 Nurse who is recognized to prescribe by the Oklahoma Board of
20 Nursing as an advanced registered nurse practitioner, clinical nurse
21 specialist or certified nurse-midwife, a Certified Nurse
22 Practitioner, Clinical Nurse Specialist, or Certified Nurse-Midwife
23 but who has not obtained independent prescriptive authority under
24 Section 1 of this act and therefore is subject to medical direction
Req. No. 12910 Page 46

1 by a current supervision agreement with a supervising physician,
2 pursuant to Section 567.3a of Title 59 of the Oklahoma Statutes, and
3 who has complied with the registration requirements of the Uniform
4 Controlled Dangerous Substances Act, in good faith and in the course
5 of professional practice only, may prescribe and administer Schedule
6 III, IV, and V controlled dangerous substances.
7 2. An Advanced Practice Registered Nurse who is recognized to
8 prescribe by the Oklahoma Board of Nursing as a Certified Nurse
9 Practitioner, Clinical Nurse Specialist, or Certified Nurse-Midwife
10 who has obtained independent prescriptive authority under Section 1
11 of this act, and who has complied with the registration requirements
12 of the Uniform Controlled Dangerous Substances Act, in good faith
13 and in the course of professional practice only, may prescribe and
14 administer Schedule III, IV, and V controlled dangerous substances.
15 D. An advanced practice nurse Advanced Practice Registered
16 Nurse who is recognized to order, select, obtain, and administer
17 drugs by the Oklahoma Board of Nursing as a certified registered
18 nurse anesthetist Certified Registered Nurse Anesthetist pursuant to
19 Section 353.1b of Title 59 of the Oklahoma Statutes and who has
20 complied with the registration requirements of the Uniform
21 Controlled Dangerous Substances Act, in good faith and in the course
22 of such practitioner’s professional practice only, may order,
23 select, obtain, and administer Schedules II through V controlled
24 dangerous substances in a preanesthetic preparation or evaluation;
Req. No. 12910 Page 47

1 anes thesia induction, maintenance, or emergence; or postanesthesia
2 care setting only. A certified registered nurse anesthetist
3 Certified Registered Nurse Anesthetist may order, select, obtain,
4 and administer such drugs only during the perioperative or
5 periobstetrical period.
6 E. A physician assistant who is recognized to prescribe by the
7 State Board of Medical Licensure and Supervision under the medical
8 direction of a supervising physician, pursuant to Section 519.6 of
9 Title 59 of the Oklahoma Statutes, and who has complied with the
10 registration requirements of the Uniform Controlled Dangerous
11 Substances Act, in good faith and in the course of professional
12 practice only, may prescribe and administer Schedule II through V
13 controlled dangerous substances.
14 SECTION 11. This act shall become effective November 1, 2025.
15
16 60-1-12910 TJ 02/25/25
17
18
19
20
21
22
23
24
Req. No. 12910 Page 48

[DELETED:  P B]
[DELETED:  P]
[DELETED:  P h h]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P f i]
[DELETED:  P]
[DELETED:  P a a a a a a]
[DELETED:  P a a a a a]
[DELETED:  P]
[DELETED:  P i h c]
[DELETED:  P]
[DELETED:  P t t t t t t t]
[DELETED:  P b u ( u b]
[DELETED:  P b]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P a a e p e i d p e t]
[DELETED:  P m c p d c p i d]
[DELETED:  P p p t p d w w]
[DELETED:  P w w w]
[DELETED:  P c f]
[DELETED:  P i a “ a]
[DELETED:  P s a a I p m e]
[DELETED:  P r A T]
[DELETED:  P a “ i]
[DELETED:  P a A]
[DELETED:  P A b p c]
[DELETED:  P T o v T T]
[DELETED:  P T A]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P f t]
[DELETED:  P C C C a E]
[DELETED:  P I]
[DELETED:  P T f f f A]
[DELETED:  P M]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P T 0]